metformin has been researched along with Acinetobacter Infections in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Acinetobacter Infections: Infections with bacteria of the genus ACINETOBACTER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, T | 1 |
| Sun, X | 1 |
| Yang, J | 1 |
| Yang, L | 1 |
| Li, M | 1 |
| Wang, Y | 1 |
| Jiao, H | 1 |
| Li, G | 1 |
1 other study available for metformin and Acinetobacter Infections
| Article | Year |
|---|---|
Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Humans; Membrane Potentials; Metformin; Minocycli | 2022 |